UNSPSC 51283925: Sulfaperin or sulfaperine

This classification denotes a sulfonamide anti-infective agent with the molecular formula C11H12N4O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier W5E840UV9P, chemically known as sulfanilamide, n(sup 1)-(5-methyl-2-pyrimidinyl)- but generally known as sulfaperin, which bears US NIH Compound Identifier 68933. European Medicines Agency schedules Sulfaperin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10720MIG. The term SULFAPERINE is an International Non-Proprietary Name.

UNSPSC 51283925 Sulfaperin or sulfaperine, a Commodity code, shows minimal alignment between its nominal scope and recent state and local procurement activity. The code's title references a specific sulfonamide pharmaceutical, yet recent opportunities posted under this code reflect procurement of naloxone, drug deactivation systems, medical and first aid supplies, and generic multi-source pharmaceuticals—none of which are sulfaperin or chemically related compounds. The mismatch suggests either systematic miscoding in the state and local procurement systems that tagged these opportunities, or a broad administrative use of this code to capture miscellaneous pharmaceutical and medical supply purchases outside their taxonomically correct categories. No recent opportunities directly soliciting sulfaperin or sulfaperine have appeared in state and local postings.

The geographic spread of the few tagged opportunities spans Florida (Seminole County), Texas (Texas Health and Human Services Commission), and Minnesota (Minnesota Multistate Cooperative Purchasing Alliance serving multiple states including Oregon). Issuing bodies include county health departments, state health agencies, fire departments, and multistate cooperative purchasing alliances. Representative recent opportunities include Seminole County's IFB60459723LAS (posted June 30, 2026, due July 26, 2023) for naloxone and drug deactivation systems with quarterly deliveries; the City of Tampa's IFB 26-P-00145 (posted March 25, 2026, due March 13, 2026) for medical and first aid supplies designated as a sheltered market for certified Small Local Business Enterprises with an estimated contract value of $700,000; and Minnesota's MMCAP RFP S1070000015802 (posted January 20, 2026, due March 26, 2026) for generic pharmaceuticals and OTC products through authorized wholesalers. The code currently shows little relevant recent activity for firms pursuing actual sulfaperin supply contracts.